Home
Responsibility
CR Report 2005
About this report

About this report

This report covers our corporate responsibility activity and performance during 2005. It updates our last corporate responsibility report published in March 2004.

Data relate to the calendar year 2005 (except where stated).

The environmental data is collected from all of our 81 pharmaceutical and consumer manufacturing sites, 5 of our 8 biologicals manufacturing sites and 19 of 21 pharmaceutical and consumer R&D sites as well as all 7 distribution centres, all 6 major office locations and 7 of the smaller office and sales locations. We include data for sites that were in operation for all or part of the year. Notes attached to the charts explain the scope and data collection process for each parameter in more detail. Unless specified as being per unit of sales, figures are absolute numbers, i.e. total consumption of energy, water etc. Data in the environment, health and safety sections of this report are externally verified, see Verification.

The scope of other data relates to our worldwide operations except where indicated.

We use external guidelines and frameworks to inform our reporting where relevant. We do not base our report on the Global Reporting Initiative guidelines but we have included a GRI index to show which elements of the guidelines we cover and to aid comparison with other company reports.

A number of changes have been made to this year’s report in response to feedback received during 2005. We have added a summary to give readers an overview of our approach to CR and the key issues for our business. Last year we organized the report according to our ten CR Principles. This year we are still reporting progress against our principles but we have reorganized some sections to make the report easier to navigate.

Information on our marketing practices, previously contained in Products and Customers, has been incorporated into the Ethical conduct section. Information previously contained in the leadership and advocacy section has been embedded through out the report, in particular in Government and external affairs, Public private partnerships and Major public health initiatives. For more information on our stakeholder engagement process see Stakeholder engagement.